Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Cumberland Pharmaceuticals Inc.”

33 pharma patents match "Cumberland Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 33
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 33 pharmaceutical patents matching "Cumberland Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

33 results for “Cumberland Pharmaceuticals Inc.” · 30,257 patents in full index Clear search

  1. US 12161632

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted

  2. US 11806400

    Injectable ibuprofen formulation

    Cumberland Pharmaceuticals Inc. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  3. US 11571412

    Thromboxane receptor antagonists in AERD/asthma

    Cumberland Pharmaceuticals Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

  4. US 10925860

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  5. US 10751383

    Doses and methods for administering telavancin

    Cumberland Pharmaceuticals Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted

  6. US 10583126

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  7. US 10456380

    Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

    Cumberland Pharmaceuticals Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  8. US 10314824

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  9. US 10064845

    Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

    Cumberland Pharmaceuticals Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  10. US 10016399

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  11. US 9931311

    Treating critically ill patients with intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  12. US 9820966

    Stabilized statin formulations

    Cumberland Pharmaceuticals Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  13. US 9693998

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

  14. US 9649284

    Treating critically ill patients with intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  15. US 9375441

    Lactulose for bowel evacuation

    Cumberland Pharmaceuticals Inc. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  16. US 9327028

    Acetylcysteine compositions and methods of use thereof

    Cumberland Pharmaceuticals Inc. · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  17. US 9295639

    Treating critically ill patients with intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  18. US 9138404

    Treating critically ill patients with intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  19. US 9114068

    Treating patients with intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  20. US 9072661

    Injectable ibuprofen formulation

    Cumberland Pharmaceuticals Inc. · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  21. US 9072710

    Injectable ibuprofen formulation

    Cumberland Pharmaceuticals Inc. · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  22. US 9012508

    Administration of intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  23. US 8952065

    Acetylcysteine composition and uses thereof

    Cumberland Pharmaceuticals Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  24. US 8933115

    Stabilized statin formulations

    Cumberland Pharmaceuticals Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.